Company news
Helix BioPharma Corp. news in 2009
Helix BioPharma Corp.'s news releases, calls and decks from 2009, newest first.
Helix BioPharma Reports On 2009 Annual General Meeting
December 9, 2009
Helix BioPharma Corp. Announces Fiscal Q1 2010 Results
December 9, 2009
Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th
November 6, 2009
Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
November 5, 2009
Helix BioPharma Corp. Announces Fiscal 2009 Results
October 29, 2009
Helix BioPharma's L-DOS47 to be Highlighted at Pharmaceutical Industry Conference
October 14, 2009
Helix BioPharma Provides Updates on Topical Interferon Alpha-2b and L-DOS47 Following Pre-IND Meetings With the U.S. FDA
October 6, 2009
Helix BioPharma Closes Private Placement
September 8, 2009
Helix BioPharma Announces $13.5 Million Private Placement
September 4, 2009
Helix Biopharma to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
September 3, 2009
Helix BioPharma Announces the Appointment of Kazimierz Roszkowski-Sliz, M.D., Ph.D., to its Board of Directors
August 17, 2009
Helix Biopharma Corp. Begins Trading on the OTCQX International Market Listing as HXBPF
June 23, 2009
Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference
June 19, 2009
Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
June 15, 2009
Helix BioPharma to Present at the BioFinance 2009 Conference
April 24, 2009
Helix BioPharma Announces Q2 2009 Financial Results
March 16, 2009
Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
March 16, 2009
Helix BioPharma Form 20-F Registration Statement Declared Effective by SEC
March 12, 2009